- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06759779
Inspiratory and Expiratory Muscle Training in Adolescent Volleyball Players
Effects of Inspiratory and Expiratory Muscle Strength Training on Respiratory Functions and Performance in Adolescent Volleyball Players
This study will investigate the effects of inspiratory and expiratory muscle training on respiratory muscle strength, pulmonary function, and performance status in adolescent athletes
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In the literature, it has been shown in a limited number of studies that respiratory muscle training in sports such as football, cycling, swimming, and rugby reduces athletes' perceived exertion levels. However, the effects of inspiratory and expiratory muscle training on respiratory muscle strength, pulmonary function, and performance status in adolescent athletes are still unclear. Therefore, this study has been planned.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Emek
-
Ankara, Emek, Turkey (Türkiye), 06490
- Gazi University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Athletes aged 12-18 who train at a submaximal level at least 3 days a week
Exclusion Criteria:
- Adolescents with any history of chronic lung disease
- unable to comply with the test and training
- unwilling to participate in the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: inspiratory muscle training group
|
Inspiratory muscle training will be performed |
|
Experimental: expiratory muscle training group
|
Expiratory muscle training will be performed |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Respiratory muscle strength
Time Frame: First day
|
Maximal inspiratory and expiratory muscle strength will be evaluated using mouth pressure device . |
First day
|
|
Diaphragm thickness
Time Frame: Second day
|
Diaphragm thickness will be assessed using ultrasonography. |
Second day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Constant load-inspiratory muscle endurance test
Time Frame: First day
|
It will be evaluated with inspiratory muscle trainer |
First day
|
|
FEV1
Time Frame: First day
|
ulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respratory Society criteria. FEV1 will be evaluated. The percentage of predicted value <70% will be expressed as abnormal |
First day
|
|
FVC
Time Frame: First day
|
ulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respratory Society criteria. FEV1 will be evaluated. The percentage of predicted value <70% will be expressed as abnormal |
First day
|
|
FEV1/FVC
Time Frame: First day
|
Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respratory Society criteria. FEV1/FVC will be evaluated. |
First day
|
|
PEF
Time Frame: First day
|
Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respratory Society criteria. PEF will be evaluated. The percentage of predicted value <70% will be expressed as abnormal |
First day
|
|
FEF2575
Time Frame: First day
|
Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respratory Society criteria. FEF2575 will be evaluated. The percentage of predicted value <50% will be expressed as abnormal |
First day
|
|
Athletic performance
Time Frame: second day
|
Performance will be evaluated with shuttle run test |
second day
|
|
Fat free mass Body compositions
Time Frame: second day
|
Fat free mass (kg) will be evaluated with bioelectrical impedance analyzer |
second day
|
|
Fat mass Body compositions
Time Frame: second day
|
Fat mass (kg) will be evaluated with bioelectrical impedance analyzer |
second day
|
|
Fat percentage Body compositions
Time Frame: second day
|
Fat percentage (%) will be evaluated with bioelectrical impedance analyzer |
second day
|
|
Diaphragm stiffness
Time Frame: second day
|
Diaphragm stiffness will be assessed using shear-wave elastography. |
second day
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 474032
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.